When everyone zigs, zag

Can we learn from what a patient's tumour is telling us in terms of what the immune system is responding to in order to target it therapeutically?

March 10, 2020

Highlights from small biotechs at SITC 2019

Highlights from SITC 2019 including small cap biotechs with novel or innovative approaches to consider

November 12, 2019

The Best Clinical Data at SITC wasn’t NextCure’s NC318 Siglec–15

Analysis and commentary of Nektar's IL-2 cytokine bempeg in combination with nivolumab in 1L advanced melanoma

November 11, 2019
National Harbor Maryland

Key Highlights from Day 1 at SITC19

If we want to improve on the current results with IO therapies then we need to go to basics and understand the biology of each disease subset in the context of what we've learned so far

November 8, 2019

SITC19 Preview: Which new IO data that grabbed our interest?

What's hot at SITC19 this year? We highlight half a dozen key presentations of interest to BSB readers and explain why they matter.

November 5, 2019

The potential of innovative mouse models to recapitulate the microbiome of cancer patients

What new things will we learn about the microbiome at SITC19?

November 4, 2019